Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREDICT UC: Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis

NCT02770040 is registered in ClinicalTrials.gov with Austin Health as lead sponsor.

NCT NCT02770040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02770040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREDICT UC: Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis
Lead sponsor
Austin Health
Phase
Phase 4
Overall status
Completed
Start date
July 18, 2016
Completion date
September 7, 2022
Enrollment
138 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis